Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Expression and Underlying Roles of IGFBP-3 in Paclitaxel-Treated Gastric Cancer Sgc-7901 Cells

  • Published : 2014.07.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: To study the expression of insulin-like growth factor binding proteins (IGFBPs) in paclitaxel-treated gastric cancer SGC-7901 cells, and to further investigate underlying mechanisms. Materials and Methods: Real time PCR and Western blot assays were applied to detect the mRNA and protein expression of IGFBP-2, -3 and -5 after paclitaxel (10 nM) treatment of SGC-7901 cells. In addition IGFBP-3 expression was silenced by RNA interference to determine effects. Cell viability was determined by MTT assay. Cell cycling and apoptosis were assessed by flow cytometry. Results: Compared to the control group, only IGFBP-3 expression was elevated significantly after paclitaxel (10 nM) treatment (p<0.05). Paclitaxel treatment caused cell cycle arrest and apoptosis via downregulating Bcl-2 expression. However, the effect could be abrogated by IGFBP-3 silencing. Conclusions: IGFBP-3 exhibits anti-apoptotic effects on paclitaxel-treated SGC-7901 cells via elevating Bcl-2 expression.

Keywords

References

  1. Adams JM, S Cory (1998). The Bcl-2 protein family: arbiters of cell survival. Science, 281, 1322-6. https://doi.org/10.1126/science.281.5381.1322
  2. Alami N, V Page, Q Yu, et al (2008). Recombinant human insulin-like growth factor-binding protein 3 inhibits tumor growth and targets the Akt pathway in lung and colon cancer models. Growth Horm IGF Res, 18, 487-96. https://doi.org/10.1016/j.ghir.2008.04.002
  3. Biernacka KM, CC Uzoh, L Zeng, et al (2013). Hyperglycaemiainduced chemoresistance of prostate cancer cells due to IGFBP2. Endocr Relat Cancer, 20, 741-51. https://doi.org/10.1530/ERC-13-0077
  4. Cortes-Sempere M, MP de Miguel, O Pernia, et al (2013). IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/ Akt pathway in non-small cell lung cancer. Oncogene, 32, 1274-83. https://doi.org/10.1038/onc.2012.146
  5. Dang YM, Huang G, Chen YR, et al (2014). Sulforaphane inhibits the proliferation of the BIU87 bladder cancer cell line via IGFBP-3 elevation. Asian Pac J Cancer Prev. 15, 1517-20. https://doi.org/10.7314/APJCP.2014.15.4.1517
  6. Duggan C, CY Wang, ML Neuhouser, et al (2013). Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer. Int J Cancer, 132, 1191-200. https://doi.org/10.1002/ijc.27753
  7. Eichhorn JM, SE Alford, N Sakurikar, et al (2014). Molecular analysis of functional redundancy among anti-apoptotic Bcl-2 proteins and its role in cancer cell survival. Exp Cell Res, 322, 415-24. https://doi.org/10.1016/j.yexcr.2014.02.010
  8. Foulstone EJ, L Zeng, CM Perks, et al (2013). Insulin-like growth factor binding protein 2 (IGFBP-2) promotes growth and survival of breast epithelial cells: novel regulation of the estrogen receptor. Endocrinology, 154, 1780-93. https://doi.org/10.1210/en.2012-1970
  9. Holdaway IM, BH Mason, AE Lethaby, et al (2003). Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 following chemotherapy for advanced breast cancer. ANZ J Surg, 73, 905-8. https://doi.org/10.1046/j.1445-2197.2003.02817.x
  10. Hossein G, Keshavarz M, Ahmadi S, et al (2012). Synergistic effects of PectaSol-C modified citrus pectin an inhibitor of galectin-3 and paclitaxel on apoptosis of human SKOV-3 ovarian cancer cells. Asian Pac J Cancer Prev, 14, 7561-8. https://doi.org/10.7314/APJCP.2013.14.12.7561
  11. Liang PI, YH Wang, TF Wu, et al (2013). IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder. J Clin Pathol, 66, 573-82. https://doi.org/10.1136/jclinpath-2012-201278
  12. Kiyoshima T, H Yoshida, H Wada, et al (2013). Chemoresistance to concanamycin A1 in human oral squamous cell carcinoma is attenuated by an HDAC inhibitor partly via suppression of Bcl-2 expression. PLoS One, 8, 80998. https://doi.org/10.1371/journal.pone.0080998
  13. Koyama S, LJ Cobb, HH Mehta, et al (2010). Pomegranate extract induces apoptosis in human prostate cancer cells by modulation of the IGF-IGFBP axis. Growth Horm IGF Res, 20, 55-62. https://doi.org/10.1016/j.ghir.2009.09.003
  14. Kalluri HS, RJ Dempsey (2011). IGFBP-3 inhibits the proliferation of neural progenitor cells. Neurochem Res, 36, 406-11. https://doi.org/10.1007/s11064-010-0349-2
  15. Williams AC, H Smartt, HZ AM, et al (2007). Insulin-like growth factor binding protein 3 (IGFBP-3) potentiates TRAIL-induced apoptosis of human colorectal carcinoma cells through inhibition of NF-kappaB. Cell Death Differ, 14, 137-45. https://doi.org/10.1038/sj.cdd.4401919
  16. Peters I, I Tossidou, J Achenbach, et al (2006). IGF-binding protein-3 modulates TGF-beta/BMP-signaling in glomerular podocytes. J Am Soc Nephrol, 17, 1644-56. https://doi.org/10.1681/ASN.2005111209
  17. Soubry A, D Il'yasova, R Sedjo, et al (2012). Increase in circulating levels of IGF-1 and IGF-1/IGFBP-3 molar ratio over a decade is associated with colorectal adenomatous polyps. Int J Cancer, 131, 512-7. https://doi.org/10.1002/ijc.26393
  18. Sunderic M, B Dukanovic, V Malenkovic, et al (2014). Molecular forms of the insulin-like growth factor-binding protein-2 in patients with colorectal cancer. Exp Mol Pathol, 96, 48-53. https://doi.org/10.1016/j.yexmp.2013.11.006
  19. Vallon M, C Seidl, B Blechert, et al (2012). Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest. Eur J Nucl Med Mol Imaging, 39, 1886-97. https://doi.org/10.1007/s00259-012-2203-z
  20. Kang WK, I Lee, U Ko, et al (2005). Differential effects of RhoA signaling on anticancer agent-induced cell death. Oncol Rep, 13, 299-304.
  21. Wang X, JJ Beitler, H Wang, et al (2014). Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis. PLoS One, 9, 86369. https://doi.org/10.1371/journal.pone.0086369
  22. Zhang GJ, Z Zhang (2013). Effect of Bcl-2 on apoptosis and transcription factor NF-kappaB activation induced by adriamycin in bladder carcinoma BIU87 cells. Asian Pac J Cancer Prev, 14, 2387-91. https://doi.org/10.7314/APJCP.2013.14.4.2387
  23. Zeng L, C Jarrett, K Brown, et al (2013). Insulin-like growth factor binding protein-3 (IGFBP-3) plays a role in the antitumorigenic effects of 5-Aza-2'-deoxycytidine (AZA) in breast cancer cells. Exp Cell Res, 319, 2282-95. https://doi.org/10.1016/j.yexcr.2013.06.011

Cited by

  1. Synergistic Anti-tumor Effect of KLF4 and Curcumin in Human Gastric Carcinoma Cell Line vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7747
  2. Detection of PIK3CA Gene Mutations with HRM Analysis and Association with IGFBP-5 Expression Levels in Breast Cancer vol.15, pp.21, 2014, https://doi.org/10.7314/APJCP.2014.15.21.9327